Erregistroa posta elektronikoz bidali: CMET-45. CHECKPOINT BLOCKADE IMMUNOTHERAPIES FOR MELANOMA BRAIN METASTASES: IMPROVED SURVIVAL OUTCOMES IN A NATIONAL COHORT